封面
市場調查報告書
商品編碼
1600579

心臟安全服務市場:按服務類型、類型和最終用戶分類 - 全球預測 2025-2030

Cardiac Safety Services Market by Service Type (Blood Pressure Measurement Services, Cardiovascular Imaging Services, ECG or Holter Measurement Services), Type (Integrated Services, Standalone Services), End-User - Global Forecast 2025-2030

出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年心臟安全服務市場價值為12.2億美元,預計到2024年將達到13.4億美元,複合年成長率為10.91%,到2030年將達到25.2億美元。

心臟安全服務包括各種評估和監測過程,旨在確保藥物化合物,尤其是新藥,不會對心臟功能產生不利影響。這些服務對於確保藥物開發階段(主要是臨床前測試期間)的法規遵循和保護病患安全至關重要。其應用涵蓋廣泛的最終用途產業,包括製藥、生物技術和 CRO(委外研發機構)。 FDA 和 EMA 等機構的嚴格監管要求推動了對心臟安全服務的需求,這些機構要求在核准藥物上市之前進行全面的心臟篩檢。心血管疾病盛行率的增加、對患者安全的日益關注以及藥物開發複雜性的增加對市場產生了重大影響。臨床試驗活動和生物相似藥上市的激增進一步推動了對這些服務的需求。主要成長動力包括影像處理和分析技術的進步,這些技術提高了心臟安全評估的效率和準確性。然而,其局限性包括高昂的營運成本、監管挑戰以及需要熟練解讀複雜心臟資料的專家。人工智慧和機器學習的整合存在新的機遇,可以簡化心臟安全通訊協定並減少人為錯誤。鼓勵公司投資開發即時監測技術和個人化醫療方法,以滿足個別患者的需求。向新興國家拓展服務的潛力巨大。儘管該行業仍然以成長為導向,但企業必須克服不斷變化的法規和市場參與者整合等挑戰。我們對診斷創新以及與技術合作夥伴的合作的關注將使我們在這個不斷變化的市場格局中獲得競爭優勢。

主要市場統計
基準年[2023] 12.2億美元
預測年份 [2024] 13.4億美元
預測年份 [2030] 25.2億美元
複合年成長率(%) 10.91%

市場動態:快速發展的心臟安全服務市場的關鍵市場洞察

供需的動態交互作用正在改變心臟安全服務市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險,同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 心血管疾病盛行率上升以及對有效和安全治療的需求
    • 使用生物相似藥和生物標記檢測心臟毒性或心血管風險
    • 政府鼓勵循環系統領域個人化治療的舉措
  • 市場限制因素
    • 心臟評估服務的成本相對較高,且熟練專業人員的數量有限
  • 市場機會
    • 心臟安全測試和監測系統的進步
    • 增加心臟治療的臨床試驗與研發
  • 市場挑戰
    • 各國缺乏監管標準化

波特五力:駕馭心臟安全服務市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰,以確保更強大的市場地位。

PESTLE分析:了解心臟安全服務市場的外部影響

外部宏觀環境因素在塑造心臟安全服務市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素,公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化,並幫助他們做出積極主動的決策。

市場佔有率分析 了解心臟安全服務市場的競爭格局

心臟安全服務市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢,為供應商提供了製定策略決策所需的洞察力,使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣心臟安全服務市場供應商的績效評估

FPNV 定位矩陣是評估心臟安全服務市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商,從而做出符合其目標的明智決策。四個象限清楚且準確地分類供應商,幫助使用者辨識最能滿足其策略目標的合作夥伴和解決方案。

本報告提供了涵蓋關鍵重點領域的全面市場分析:

1. 市場滲透率:對當前市場環境的詳細回顧,包括行業主要企業的大量資料。

2. 市場開拓:辨識新興市場的成長機會,評估現有領域的擴張潛力,並提供未來成長的策略藍圖。

3. 市場多元化:分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報:徹底分析競爭格局,檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新:重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題,以幫助相關人員做出明智的決策:

1.目前的市場規模和未來的成長預測是多少?

2. 哪些產品、區隔市場和地區提供最佳投資機會?

3.塑造市場的主要技術趨勢和監管影響是什麼?

4.主要廠商的市場佔有率和競爭地位如何?

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼?

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 心血管疾病發生率上升以及有效和安全治療的需求
      • 使用生物相似藥和生物標記檢測心臟毒性或心血管風險
      • 政府鼓勵心臟病學個人化治療的舉措
    • 抑制因素
      • 心臟評估服務的成本相對較高,且缺乏熟練的專業人員。
    • 機會
      • 心臟安全測試和監測系統的進步
      • 增加心臟治療的臨床試驗與研發
    • 任務
      • 各國缺乏監管標準化
  • 市場區隔分析
    • 服務類型:對高效心血管影像服務的需求不斷增加
    • 類型:擴大綜合心臟安全服務在藥物開發的使用
    • 最終用戶:製藥和生物製藥公司對心臟安全服務的採用激增
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境
  • 客戶客製化

第6章心臟安全服務市場:依服務類型

  • 血壓測量服務
  • 心血管影像服務
  • 心電圖或動態心電圖測量服務
  • 全面的 QT 研究

第7章心臟安全服務市場:依類型

  • 綜合服務
  • 獨立服務

第8章心臟安全服務市場:依最終用戶分類

  • 合約調查機構
  • 製藥和生物製藥公司

第9章美洲心臟安全服務市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太心臟安全服務市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲心臟安全服務市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣,2023
  • 競爭情境分析
    • OSF Healthcare 與 Bellin Health 合作擴大Delta縣的心血管服務
    • Jubilant Radiopharma 和 Cardiac Imaging, Inc. 宣佈建立獨家合作夥伴關係,以擴大行動心臟 PET 服務的覆蓋範圍
    • GE Healthcare 推出適用於心血管疾病患者的 Vscan Air SL 設備
    • Clario 和 AliveCor 合作提供先進的、特定於試驗的 6 導程心電圖解決方案,用於分散式臨床試驗監測
    • Metrion Biosciences 宣布推出 GLP hERG篩檢服務
    • Heartnet 推出遠距心臟病學產品 ASAAN
    • AliveCor 和 Luscii 合作開發“Heart Clinic In a Box”
    • Abbott 全球首款雙腔室無導線心律調節器獲得 FDA核准
    • 飛利浦和 Biotronic 合作擴大院外心臟病學實驗室的護理
    • 雅培完成對心血管系統公司 8.9 億美元的收購
    • 飛利浦和 TriHealth 宣佈在貝塞斯達北醫院園區新 TriHealth 心血管研究所的核心區域建立多年夥伴關係
    • 巴努克集團開設美國辦事處,並持續全球擴張

公司名單

  • Lunit Inc.
  • NEXEL Co., Ltd.
  • Tempus Labs, Inc.
  • Certara, Inc.
  • Toray Medical Company Limited by Toray Industries
  • Metrion Biosciences Limited
  • Circle Cardiovascular Imaging Inc.
  • Medpace, Inc.
  • Butterfly Network Inc.
  • GE HealthCare Technologies Inc.
  • Ncardia Services BV
  • Shanghai Medicilon Inc.
  • Thermo Fisher Scientific Inc.
  • Octagos Health, Inc.
  • Richmond Pharmacology Limited
  • Banook Group
  • IQVIA Holdings Inc.
  • Abbott Laboratories
  • Koninklijke Philips NV
  • Clario
  • Siemens Healthcare GmbH
  • PhysioStim SAS
  • Biotrial
  • MERIT CRO, Inc.
  • Dozee
  • AliveCor, Inc.
  • Laboratory Corporation of America Holdings
  • Clyde Biosciences Limited
  • Eurofins Scientific SE
  • ICON PLC
  • Celerion
Product Code: MRR-034230D3E2D5

The Cardiac Safety Services Market was valued at USD 1.22 billion in 2023, expected to reach USD 1.34 billion in 2024, and is projected to grow at a CAGR of 10.91%, to USD 2.52 billion by 2030.

Cardiac Safety Services encompass a range of assessments and monitoring processes designed to ensure that pharmaceutical compounds, especially new drugs, do not adversely affect the heart's function. These services are crucial in drug development phases, primarily during preclinical trials, to ensure regulatory compliance and protect patient safety. Their application spans a wide range of end-use industries, including pharmaceuticals, biotechnology, and CROs (Contract Research Organizations). The necessity of cardiac safety services is driven by stringent regulatory mandates from bodies like the FDA and EMA, which require comprehensive cardiac screening before a drug can be approved for market release. The market is heavily influenced by the increasing prevalence of cardiovascular diseases, heightened focus on patient safety, and the growing complexities of drug development. A surge in clinical trial activities and biosimilar launches further propels the demand for these services. Key growth drivers include advancements in imaging and analytics technology, enhancing the efficiency and accuracy of cardiac safety assessments. However, the market faces limitations such as high operational costs, regulatory challenges, and the need for skilled professionals proficient in interpreting complex cardiac data. Emerging opportunities exist in the integration of artificial intelligence and machine learning, aiming to streamline cardiac safety protocols and reduce human error. Businesses are recommended to invest in developing real-time monitoring technologies and personalized medicine approaches, catering to individual patient needs. There's a notable potential in expanding services to developing countries, where the market penetration of cardiac safety services is still low. While the industry remains growth-oriented, companies must navigate challenges such as evolving regulations and the consolidation of market players. A focus on innovation in diagnostic methods and collaboration with technological partners will provide a competitive edge in this evolving market landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 1.22 billion
Estimated Year [2024] USD 1.34 billion
Forecast Year [2030] USD 2.52 billion
CAGR (%) 10.91%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cardiac Safety Services Market

The Cardiac Safety Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidence of cardiovascular disorders and the need for effective & safe treatment
    • Use of biosimilars and biomarkers to detect cardiotoxicity or cardiovascular risks
    • Government initiatives encouraging personalized treatments in cardiology
  • Market Restraints
    • Relatively high cost of cardiac evaluation services and limited availability of skilled professionals
  • Market Opportunities
    • Advancements in cardiac safety testing and monitoring systems
    • Growing number of clinical trials and R&D for cardiac treatments
  • Market Challenges
    • Lack of regulatory standardization across various countries

Porter's Five Forces: A Strategic Tool for Navigating the Cardiac Safety Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cardiac Safety Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cardiac Safety Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cardiac Safety Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cardiac Safety Services Market

A detailed market share analysis in the Cardiac Safety Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cardiac Safety Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cardiac Safety Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Cardiac Safety Services Market, highlighting leading vendors and their innovative profiles. These include Lunit Inc., NEXEL Co., Ltd., Tempus Labs, Inc., Certara, Inc., Toray Medical Company Limited by Toray Industries, Metrion Biosciences Limited, Circle Cardiovascular Imaging Inc., Medpace, Inc., Butterfly Network Inc., GE HealthCare Technologies Inc., Ncardia Services B.V., Shanghai Medicilon Inc., Thermo Fisher Scientific Inc., Octagos Health, Inc., Richmond Pharmacology Limited, Banook Group, IQVIA Holdings Inc., Abbott Laboratories, Koninklijke Philips N.V., Clario, Siemens Healthcare GmbH, PhysioStim SAS, Biotrial, MERIT CRO, Inc., Dozee, AliveCor, Inc., Laboratory Corporation of America Holdings, Clyde Biosciences Limited, Eurofins Scientific SE, ICON PLC, and Celerion.

Market Segmentation & Coverage

This research report categorizes the Cardiac Safety Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Service Type, market is studied across Blood Pressure Measurement Services, Cardiovascular Imaging Services, ECG or Holter Measurement Services, and Thorough QT Studies.
  • Based on Type, market is studied across Integrated Services and Standalone Services.
  • Based on End-User, market is studied across Contract Research Organizations and Pharmaceutical & Biopharmaceutical Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of cardiovascular disorders and the need for effective & safe treatment
      • 5.1.1.2. Use of biosimilars and biomarkers to detect cardiotoxicity or cardiovascular risks
      • 5.1.1.3. Government initiatives encouraging personalized treatments in cardiology
    • 5.1.2. Restraints
      • 5.1.2.1. Relatively high cost of cardiac evaluation services and limited availability of skilled professionals
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in cardiac safety testing and monitoring systems
      • 5.1.3.2. Growing number of clinical trials and R&D for cardiac treatments
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of regulatory standardization across various countries
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Service Type: Proliferating need for efficient cardiovascular imaging services
    • 5.2.2. Type: Expanding use of integrated cardiac safety services for drug development
    • 5.2.3. End-User: Surging adoption of cardiac safety services by pharmaceutical & biopharmaceutical companies
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental
  • 5.5. Client Customization

6. Cardiac Safety Services Market, by Service Type

  • 6.1. Introduction
  • 6.2. Blood Pressure Measurement Services
  • 6.3. Cardiovascular Imaging Services
  • 6.4. ECG or Holter Measurement Services
  • 6.5. Thorough QT Studies

7. Cardiac Safety Services Market, by Type

  • 7.1. Introduction
  • 7.2. Integrated Services
  • 7.3. Standalone Services

8. Cardiac Safety Services Market, by End-User

  • 8.1. Introduction
  • 8.2. Contract Research Organizations
  • 8.3. Pharmaceutical & Biopharmaceutical Companies

9. Americas Cardiac Safety Services Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cardiac Safety Services Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cardiac Safety Services Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. OSF HealthCare Establishes a Partnership with Bellin Health to Expand Cardiovascular Services in Delta County
    • 12.3.2. Jubilant Radiopharma and Cardiac Imaging, Inc. Announce Exclusive Partnership to Expand Access for Mobile Cardiac PET Offering
    • 12.3.3. GE HealthCare Announces Vscan Air SL Device for Cardiac, Vascular Patients
    • 12.3.4. Clario and AliveCor Collaborate to Offer Advanced, Trial-Focused Six-Lead ECG Solutions for Monitoring in Decentralized Clinical Trials
    • 12.3.5. Metrion Biosciences Announces Launch of Good Laboratory Practice (GLP) hERG Screening Service
    • 12.3.6. Heartnet Launches Telecardiology Product ASAAN
    • 12.3.7. AliveCor, Luscii Partner On 'Heart Clinic In a Box'
    • 12.3.8. Abbott Receives FDA Approval for World's First Dual Chamber Leadless Pacemaker
    • 12.3.9. Philips, Biotronik Partner to Expand Care for Out-of-Hospital Cardiology Labs
    • 12.3.10. Abbott Completes USD 890 Million Acquisition of Cardiovascular Systems
    • 12.3.11. Philips and TriHealth Announce Multi-Year Partnership at Heart of New Trihealth Heart & Vascular Institute on the Campus of Bethesda North Hospital
    • 12.3.12. Banook Group Continues Global Expansion with the U.S. Office Opening

Companies Mentioned

  • 1. Lunit Inc.
  • 2. NEXEL Co., Ltd.
  • 3. Tempus Labs, Inc.
  • 4. Certara, Inc.
  • 5. Toray Medical Company Limited by Toray Industries
  • 6. Metrion Biosciences Limited
  • 7. Circle Cardiovascular Imaging Inc.
  • 8. Medpace, Inc.
  • 9. Butterfly Network Inc.
  • 10. GE HealthCare Technologies Inc.
  • 11. Ncardia Services B.V.
  • 12. Shanghai Medicilon Inc.
  • 13. Thermo Fisher Scientific Inc.
  • 14. Octagos Health, Inc.
  • 15. Richmond Pharmacology Limited
  • 16. Banook Group
  • 17. IQVIA Holdings Inc.
  • 18. Abbott Laboratories
  • 19. Koninklijke Philips N.V.
  • 20. Clario
  • 21. Siemens Healthcare GmbH
  • 22. PhysioStim SAS
  • 23. Biotrial
  • 24. MERIT CRO, Inc.
  • 25. Dozee
  • 26. AliveCor, Inc.
  • 27. Laboratory Corporation of America Holdings
  • 28. Clyde Biosciences Limited
  • 29. Eurofins Scientific SE
  • 30. ICON PLC
  • 31. Celerion

LIST OF FIGURES

  • FIGURE 1. CARDIAC SAFETY SERVICES MARKET RESEARCH PROCESS
  • FIGURE 2. CARDIAC SAFETY SERVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES CARDIAC SAFETY SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES CARDIAC SAFETY SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. CARDIAC SAFETY SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. CARDIAC SAFETY SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CARDIAC SAFETY SERVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CARDIAC SAFETY SERVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY BLOOD PRESSURE MEASUREMENT SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY CARDIOVASCULAR IMAGING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY ECG OR HOLTER MEASUREMENT SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY THOROUGH QT STUDIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY INTEGRATED SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY STANDALONE SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES CARDIAC SAFETY SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. CARDIAC SAFETY SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. CARDIAC SAFETY SERVICES MARKET, FPNV POSITIONING MATRIX, 2023